ENTG.NASDAQEntegris INC

Form 4: Entegris Executive Chair Sells Over 100K Shares

Sentiment:

Insider Trading Report


Entegris Executive Chair Bertrand Loy exercised options and sold a significant number of common shares under a pre-arranged trading plan.

Worse than expectedThe Executive Chair sold a substantial number of shares, which can be perceived negatively by investors as it reduces insider ownership.While the sales were pre-planned under a Rule 10b5-1 plan, the sheer volume of shares sold (109,838) could indicate a lack of conviction in the stock's near-term appreciation potential from the insider's perspective, or simply a diversification/liquidity event.

Summary

  • Bertrand Loy, Executive Chair and Director of Entegris, Inc. (ENTG), reported transactions involving the company's common stock.
  • Loy exercised 9,838 employee stock options at a price of $98.11 per share on February 24, 2026.
  • Following the option exercise, Loy sold a total of 109,838 shares of common stock across multiple transactions on February 24 and February 25, 2026.
  • The sales were executed at weighted average prices ranging from $137.32 to $142.19 per share.
  • All reported sales were conducted pursuant to a Rule 10b5-1 trading plan established on February 10, 2025.
  • After these transactions, Loy directly beneficially owns 217,767 shares of common stock and 61,534 employee stock options.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative signal due to the significant volume of shares sold by a key executive, even though it was pre-planned. While not indicative of immediate distress, it suggests the executive is taking profits at current valuations.

Positives

  • The exercise of employee stock options at $98.11 indicates a gain for the reporting person given the subsequent sale prices.
  • The transactions were conducted under a pre-established Rule 10b5-1 trading plan, which provides an affirmative defense against insider trading allegations.

Negatives

  • Executive Chair Bertrand Loy sold a substantial number of shares (109,838 shares) over two days.
  • The sales represent a reduction in direct beneficial ownership of common stock from 327,605 shares (before sales, after exercise) to 217,767 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a signal, particularly in the semiconductor industry which is sensitive to economic cycles and technological shifts. While these sales are pre-planned, they occur at a time when the company's stock price is trading significantly above the option exercise price.

Stakeholder Impact

  • Shareholders: May interpret the significant insider selling as a negative signal, potentially leading to downward pressure on the stock price.
  • Employees: No direct impact mentioned, but general market sentiment could affect employee stock options/grants.

Key Dates

DateDescription
02/10/2025Date Rule 10b5-1 Trading Plan was established by Bertrand Loy.
02/24/2026Date of employee stock option exercise and multiple common stock sales.
02/25/2026Date of additional common stock sales.
02/26/2026Date the Form 4 was signed by Attorney-in-Fact Joseph Colella.
02/19/2028Expiration date of the exercised employee stock option.

Recommendation

hold

While the significant insider selling by the Executive Chair is a notable event, it was conducted under a pre-established 10b5-1 plan, which often indicates a planned liquidity event rather than a sudden loss of confidence. The company's underlying fundamentals and broader market conditions should be the primary drivers for investment decisions. Investors should monitor future insider activity and company performance, but this filing alone does not warrant a 'sell' recommendation without further context on the company's operational health or strategic direction. A 'hold' recommendation is appropriate to assess further developments.

Keywords

Entegris, ENTG, Bertrand Loy, Insider Trading, Form 4, Stock Sale, Option Exercise, Rule 10b5-1, Executive Chair, Semiconductor Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.